However ,  none of the studies couldc onfirm the statistically significant overall effect on the frequency of liver metastases  reported by Taylor et al. It seems likely that the effect of adjuvant portal chemotherapy on overall and disease-free survival can be attributed to the systemic effects of intraportal fluorouracil ,  which lead to a reduction in all tumour relapses (ie ,  local recurrences ,  liver metastases ,  and other distant metastases) .
